CN113252807A - 一种缩宫素原料药有关物质的高效液相色谱分离方法 - Google Patents
一种缩宫素原料药有关物质的高效液相色谱分离方法 Download PDFInfo
- Publication number
- CN113252807A CN113252807A CN202110405902.3A CN202110405902A CN113252807A CN 113252807 A CN113252807 A CN 113252807A CN 202110405902 A CN202110405902 A CN 202110405902A CN 113252807 A CN113252807 A CN 113252807A
- Authority
- CN
- China
- Prior art keywords
- oxytocin
- high performance
- performance liquid
- liquid chromatography
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960001723 oxytocin Drugs 0.000 title claims abstract description 73
- 101800000989 Oxytocin Proteins 0.000 title claims abstract description 70
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 title claims abstract description 70
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title claims abstract description 70
- 238000000926 separation method Methods 0.000 title claims abstract description 34
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 33
- 239000002994 raw material Substances 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 title claims abstract 18
- 239000000126 substance Substances 0.000 title claims description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000012535 impurity Substances 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000007853 buffer solution Substances 0.000 claims abstract description 18
- 229940088679 drug related substance Drugs 0.000 claims abstract description 12
- 238000010828 elution Methods 0.000 claims abstract description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000945 filler Substances 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 239000000741 silica gel Substances 0.000 claims abstract description 4
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 13
- 239000000872 buffer Substances 0.000 claims description 10
- QWSZRRAAFHGKCH-UHFFFAOYSA-M sodium;hexane-1-sulfonate Chemical compound [Na+].CCCCCCS([O-])(=O)=O QWSZRRAAFHGKCH-UHFFFAOYSA-M 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 239000012085 test solution Substances 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 7
- 239000012488 sample solution Substances 0.000 claims description 7
- 239000003643 water by type Substances 0.000 claims description 4
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 claims description 3
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 3
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 claims description 3
- ROBLTDOHDSGGDT-UHFFFAOYSA-M sodium;pentane-1-sulfonate Chemical compound [Na+].CCCCCS([O-])(=O)=O ROBLTDOHDSGGDT-UHFFFAOYSA-M 0.000 claims description 3
- -1 Phenyl-Hexyl Chemical group 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 9
- 238000011160 research Methods 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 4
- 102400000050 Oxytocin Human genes 0.000 description 52
- 229940090044 injection Drugs 0.000 description 7
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003726 vasopressin Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- AAEQXEDPVFIFDK-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-n,3-diphenyloxirane-2-carboxamide Chemical compound C=1C=CC=CC=1NC(=O)C1(C(=O)C(C)C)OC1(C=1C=CC=CC=1)C(=O)C1=CC=C(F)C=C1 AAEQXEDPVFIFDK-UHFFFAOYSA-N 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 102000004279 Oxytocin receptors Human genes 0.000 description 1
- 108090000876 Oxytocin receptors Proteins 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000006240 deamidation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XNOPRXBHLZRZKH-MQYCRUOZSA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1C(CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-MQYCRUOZSA-N 0.000 description 1
- 229940082408 oxytocin injection Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/74—Optical detectors
Landscapes
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
时间/min | 流动相A | 流动相B |
0~15 | 60% | 40% |
15~30 | 60%~40% | 40%~60% |
30~60 | 40% | 60% |
时间/min | 流动相A | 流动相B |
0~15 | 60% | 40% |
15~30 | 60%~40% | 40%~60% |
30~60 | 40% | 60% |
时间/min | 流动相A | 流动相B |
0~15 | 60% | 40% |
15~30 | 60%~40% | 40%~60% |
30~60 | 40% | 60% |
名称 | 保留时间 | 分离度 |
杂质A | 9.237 | 1.52 |
缩宫素 | 9.741 | 13.83 |
杂质B | 未检出 | 未检出 |
杂质D | 14.733 | 1.7 |
杂质C | 15.294 | 35.22 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110405902.3A CN113252807B (zh) | 2021-04-15 | 2021-04-15 | 一种缩宫素原料药有关物质的高效液相色谱分离方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110405902.3A CN113252807B (zh) | 2021-04-15 | 2021-04-15 | 一种缩宫素原料药有关物质的高效液相色谱分离方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113252807A true CN113252807A (zh) | 2021-08-13 |
CN113252807B CN113252807B (zh) | 2022-05-06 |
Family
ID=77220803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110405902.3A Active CN113252807B (zh) | 2021-04-15 | 2021-04-15 | 一种缩宫素原料药有关物质的高效液相色谱分离方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113252807B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113827700A (zh) * | 2021-09-30 | 2021-12-24 | 上海上药第一生化药业有限公司 | 含缩宫素的药物组合物及其冻干粉、缩宫素的纯化方法 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648352A (en) * | 1991-09-13 | 1997-07-15 | Merck & Co., Inc. | Piperazinylcamphorsulfonyl oxytocin antagonists |
US20050133452A1 (en) * | 2003-11-21 | 2005-06-23 | Akzo Nobel N.V. | Separation method |
CN102977192A (zh) * | 2012-12-06 | 2013-03-20 | 安徽工程大学 | 一种卡贝缩宫素的纯化方法 |
JP2016114573A (ja) * | 2014-12-18 | 2016-06-23 | 国立大学法人金沢大学 | オキシトシン検出のためのサンプルの前処理方法 |
US20160377635A1 (en) * | 2013-06-26 | 2016-12-29 | Martin-Protean Llc | Measurement of Oxytocin and Vasopressin |
CN108445116A (zh) * | 2018-03-14 | 2018-08-24 | 中国科学院大连化学物理研究所 | 一种生物体液样品中游离催产素前处理方法 |
CN110308222A (zh) * | 2019-07-17 | 2019-10-08 | 武汉赛沃医药科技有限公司 | 一种卡贝缩宫素原料药有关物质检测方法 |
CN110658296A (zh) * | 2019-10-30 | 2020-01-07 | 海南通用三洋药业有限公司 | 一种醋酸阿托西班注射液中高分子聚合物的检测方法 |
CN111077243A (zh) * | 2019-12-16 | 2020-04-28 | 成都市海通药业有限公司 | 一种用于缩宫素注射液的检测方法 |
CN111812240A (zh) * | 2020-07-15 | 2020-10-23 | 上海上药第一生化药业有限公司 | 一种缩宫素及三种杂质的分离方法和应用 |
CN111830154A (zh) * | 2020-07-15 | 2020-10-27 | 上海上药第一生化药业有限公司 | 一种缩宫素及其8种差向异构体的分离方法及应用 |
CN111912917A (zh) * | 2020-07-15 | 2020-11-10 | 上海上药第一生化药业有限公司 | 一种缩宫素及至少十种杂质的分离方法和应用 |
-
2021
- 2021-04-15 CN CN202110405902.3A patent/CN113252807B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648352A (en) * | 1991-09-13 | 1997-07-15 | Merck & Co., Inc. | Piperazinylcamphorsulfonyl oxytocin antagonists |
US20050133452A1 (en) * | 2003-11-21 | 2005-06-23 | Akzo Nobel N.V. | Separation method |
CN102977192A (zh) * | 2012-12-06 | 2013-03-20 | 安徽工程大学 | 一种卡贝缩宫素的纯化方法 |
US20160377635A1 (en) * | 2013-06-26 | 2016-12-29 | Martin-Protean Llc | Measurement of Oxytocin and Vasopressin |
JP2016114573A (ja) * | 2014-12-18 | 2016-06-23 | 国立大学法人金沢大学 | オキシトシン検出のためのサンプルの前処理方法 |
CN108445116A (zh) * | 2018-03-14 | 2018-08-24 | 中国科学院大连化学物理研究所 | 一种生物体液样品中游离催产素前处理方法 |
CN110308222A (zh) * | 2019-07-17 | 2019-10-08 | 武汉赛沃医药科技有限公司 | 一种卡贝缩宫素原料药有关物质检测方法 |
CN110658296A (zh) * | 2019-10-30 | 2020-01-07 | 海南通用三洋药业有限公司 | 一种醋酸阿托西班注射液中高分子聚合物的检测方法 |
CN111077243A (zh) * | 2019-12-16 | 2020-04-28 | 成都市海通药业有限公司 | 一种用于缩宫素注射液的检测方法 |
CN111812240A (zh) * | 2020-07-15 | 2020-10-23 | 上海上药第一生化药业有限公司 | 一种缩宫素及三种杂质的分离方法和应用 |
CN111830154A (zh) * | 2020-07-15 | 2020-10-27 | 上海上药第一生化药业有限公司 | 一种缩宫素及其8种差向异构体的分离方法及应用 |
CN111912917A (zh) * | 2020-07-15 | 2020-11-10 | 上海上药第一生化药业有限公司 | 一种缩宫素及至少十种杂质的分离方法和应用 |
Non-Patent Citations (2)
Title |
---|
DUNGE ASHENAFI ET AL.: "Liquid chromatographic analysis of oxytocin and its related substances", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
黄青 等: "缩宫素注射液的有关物质研究", 《药物分析杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113827700A (zh) * | 2021-09-30 | 2021-12-24 | 上海上药第一生化药业有限公司 | 含缩宫素的药物组合物及其冻干粉、缩宫素的纯化方法 |
CN113827700B (zh) * | 2021-09-30 | 2024-06-04 | 上海上药第一生化药业有限公司 | 含缩宫素的药物组合物及其冻干粉、缩宫素的纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113252807B (zh) | 2022-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113252807B (zh) | 一种缩宫素原料药有关物质的高效液相色谱分离方法 | |
CN114280176A (zh) | 一种hplc检测恶拉戈利中有关物质的方法 | |
CN109959736B (zh) | 使用氨基酸分析仪测定氨甲环酸含量的方法 | |
CN116482268A (zh) | 一种阿加曲班原料或制剂中杂质的检测方法 | |
CN111912917B (zh) | 一种缩宫素及至少十种杂质的分离方法和应用 | |
CN111830154B (zh) | 一种缩宫素及其8种差向异构体的分离方法及应用 | |
CN111812240B (zh) | 一种缩宫素及三种杂质的分离方法和应用 | |
CN110208397A (zh) | 一种同时测定土霉素氟尼辛注射液中两种主药含量的高效液相色谱法 | |
CN106943342B (zh) | 一种含有阿加曲班的药物组合物 | |
CN111896642B (zh) | 一种缩宫素及三种脱酰胺杂质的分离方法和应用 | |
CN106525987A (zh) | 一种奈达铂的杂质检测方法 | |
CN110841055A (zh) | 一种具有宫缩作用药物组合物的生产方法 | |
Chaibva | Development and Assessment of an Oxytocin Parenteral Dosage Form Prepared Using Pluronic® F127 | |
CN111812227A (zh) | 一种多巴丝肼复方制剂中苄丝肼杂质a的分析方法 | |
CN117849225A (zh) | 一种缩宫素有关物质的检测方法 | |
CN115656402A (zh) | 一种奈玛特韦有关物质的检测方法 | |
CN115932122A (zh) | 一种基于rp-hplc内标法测定保护氨基酸中残留乙酸的分析方法 | |
CN110934822A (zh) | 包含卡贝缩宫素的药物组合物及其应用 | |
CN116297885A (zh) | 一种黄体酮有关物质的检测方法 | |
CN117907506A (zh) | 一种醋酸阿托西班杂质的超高效液相色谱检测方法 | |
CN115716863A (zh) | 一种生长抑素杂质的控制方法 | |
CN116413348A (zh) | 一种分离多巴胺及其有关物质的方法 | |
CN117074572A (zh) | 一种1,4-二甲基-7-异丙基薁-3-磺酸钠及其相关制剂的有关物质检测方法 | |
CN105012230B (zh) | 一种依达拉奉的药物组合物 | |
CN113908120A (zh) | 布立西坦药物溶液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Applicant after: Yuanda Life Science (Wuhan) Co.,Ltd. Address before: 430040 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Applicant before: WUHAN DOCAN PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 430000 No.1 Xiaoxiang West Road, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Medical Nutrition Science (Wuhan) Co.,Ltd. Country or region after: China Address before: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: Yuanda Life Science (Wuhan) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |